Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Lipkowski

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2000
A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesicS E Foran, D B Carr, A W Lipkowski, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Inhibition of morphine tolerance development by a substance P-opioid peptide chimeraS E Foran, D B Carr, A W Lipkowski, et al.
Life Sciences|May 7, 1998
[125I-Tyr1]biphalin binding to opioid receptors of rat brain and NG108-15 cell membranesJ Slaninova, S M Appleyard, A Misicka, et al.
Biochemical and Biophysical Research Communications|November 14, 1991
Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activityA Misicka, A W Lipkowski, L Fang, et al.
Journal of Medicinal Chemistry|September 1, 1985
Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptorsP S Portoghese, D L Larson, C B Yim, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeabilityD L Greene, V S Hau, T J Abbruscato, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogsS J Weber, T J Abbruscato, E A Brownson, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptideG Li, W Haq, L Xiang, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2000
A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesicS E Foran, D B Carr, A W Lipkowski, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Inhibition of morphine tolerance development by a substance P-opioid peptide chimeraS E Foran, D B Carr, A W Lipkowski, et al.
Life Sciences|May 7, 1998
[125I-Tyr1]biphalin binding to opioid receptors of rat brain and NG108-15 cell membranesJ Slaninova, S M Appleyard, A Misicka, et al.
Biochemical and Biophysical Research Communications|November 14, 1991
Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activityA Misicka, A W Lipkowski, L Fang, et al.
Journal of Medicinal Chemistry|September 1, 1985
Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptorsP S Portoghese, D L Larson, C B Yim, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeabilityD L Greene, V S Hau, T J Abbruscato, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogsS J Weber, T J Abbruscato, E A Brownson, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptideG Li, W Haq, L Xiang, et al.
Pageof 9